LeaderPortfolio
Moderna
healthcare Cambridge, Massachusetts Est. 2010

Moderna

Market Cap
$21.04B
Stock Price
$51.34
MRNA
Moderna
Revenue$1.94B
Employees5,800

Corporate Profile

Moderna stands as a titan in the healthcare sector. With a valuation of $21.04 Billion, the company employs over 5,800 people worldwide. Headquartered in Cambridge, Massachusetts, it continues to drive innovation and maintain its market dominance.

Moderna is a healthcare company tracked by Billionaire Net Worth for its role in global business, public-company valuation, and billionaire wealth creation. The company profile includes ticker MRNA, headquarters in Cambridge, Massachusetts, founded in 2010, 5,800 employees. Its financial snapshot shows market capitalization of about $21 billion, annual revenue of about $1.9 billion, recent stock price data near $51.34. This profile is designed to help readers understand how Moderna's business fundamentals, ownership structure, and market position relate to wealth rankings and billionaire portfolios.

Strategy, capital, and competitive context

Moderna operates in healthcare with headquarters in Cambridge, Massachusetts (founded 2010). The headline market cap of $21.04B reflects how public markets are pricing the equity right now; it can swing on rates, sector sentiment, and a handful of product cycles. Revenue of $1.94B is shown as a coarse annualized snapshot for orientation—always compare to the latest audited financials.

From a capital-allocation lens, we watch how reinvestment (R&D, capex, M&A) maps to returns and balance-sheet flexibility. A wide gap between revenue growth and multiple expansion often signals shifting expectations about moat durability, regulation, or geographic mix. Where we publish charts, they are built from the site's structured history fields and may be interpolated when filings are sparse—see methodology for limitations.

Competitive benchmarking on this page uses linked peers when available; treat it as a starting point for industry mapping, not a buy/sell screen. Ticker MRNA is displayed for convenience; verify exchange codes before trading.

Editorial note: this section is authored in-house to explain how we connect metrics to meaning. It is updated when material fundamentals change; report issues on corrections.

Financial History

Verified multi-year history for Moderna is not yet available in our database. We publish charts only from documented data points—not synthetic estimates.

Read our methodology

In-Depth Analysis

Moderna is a healthcare company tracked by Billionaire Net Worth for its role in global business, public-company valuation, and billionaire wealth creation. The company profile includes ticker MRNA, headquarters in Cambridge, Massachusetts, founded in 2010, 5,800 employees. Its financial snapshot shows market capitalization of about $21 billion, annual revenue of about $1.9 billion, recent stock price data near $51.34. This profile is designed to help readers understand how Moderna's business fundamentals, ownership structure, and market position relate to wealth rankings and billionaire portfolios.

Data Sources & Methodology

Figures for Moderna are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.